SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ChromaDex Corp. – ‘10-Q’ for 7/1/17 – ‘EX-10.7’

On:  Thursday, 8/10/17, at 4:01pm ET   ·   For:  7/1/17   ·   Accession #:  1654954-17-7224   ·   File #:  1-37752

Previous ‘10-Q’:  ‘10-Q’ on 5/11/17 for 4/1/17   ·   Next:  ‘10-Q’ on 11/9/17 for 9/30/17   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/17  ChromaDex Corp.                   10-Q        7/01/17   56:3.8M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    531K 
 2: EX-10.1     Third Business Financing Modification Agreement     HTML     50K 
 3: EX-10.5     License Agreement                                   HTML    144K 
 4: EX-10.6     Research Funding Agreement                          HTML     83K 
 5: EX-10.7     Fourth Business Financing Modification Agreement    HTML     47K 
 6: EX-10.8     Amended and Restated Non-Employee Director          HTML     26K 
                Compensation Policy                                              
 7: EX-31.1     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     22K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 8: EX-31.2     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     22K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 9: EX-32.1     Certificate Pursuant to Section 18 U.S.C. Pursuant  HTML     18K 
                to Section 906 of the Sarbanes-Oxley Act of 2002                 
16: R1          Document and Entity Information                     HTML     42K 
17: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML     91K 
18: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     29K 
                (Parenthetical)                                                  
19: R4          Condensed Consolidated Statements of Operations     HTML     79K 
                (Unaudited)                                                      
20: R5          Condensed Consolidated Statement of Stockholders'   HTML     61K 
                Equity (Unaudited) (Usd $)                                       
21: R6          Condensed Consolidated Statement of Stockholders'   HTML     19K 
                Equity (Usd $) (Parenthetical)                                   
22: R7          Condensed Consolidated Statements of Cash Flows     HTML    112K 
                (Unaudited)                                                      
23: R8          Interim Financial Statements                        HTML     22K 
24: R9          Nature of Business and Liquidity                    HTML     25K 
25: R10         Significant Accounting Policies                     HTML     26K 
26: R11         Earnings Per Share Applicable to Common             HTML     34K 
                Stockholders                                                     
27: R12         Asset Acquisition and Related Party Transaction     HTML     28K 
28: R13         Trade Receivables Allowances                        HTML     23K 
29: R14         Inventories                                         HTML     24K 
30: R15         Employee Share-Based Compensation                   HTML     37K 
31: R16         Stock Issuance                                      HTML     20K 
32: R17         Business Segments                                   HTML     85K 
33: R18         Commitments and Contingencies                       HTML     33K 
34: R19         Other Expense                                       HTML     20K 
35: R20         Significant Accounting Policies (Policies)          HTML     28K 
36: R21         Earnings Per Share Applicable to Common             HTML     35K 
                Stockholders (Tables)                                            
37: R22         Asset Acquisition and Related Party Transaction     HTML     24K 
                (Tables)                                                         
38: R23         Trade Receivables Allowances (Tables)               HTML     22K 
39: R24         Inventories (Tables)                                HTML     25K 
40: R25         Employee Share-Based Compensation (Tables)          HTML     33K 
41: R26         Business Segments (Tables)                          HTML     88K 
42: R27         Nature of Business and Liquidity (Details           HTML     26K 
                Narrative)                                                       
43: R28         Earnings Per Share Applicable to Common             HTML     47K 
                Stockholders (Details)                                           
44: R29         Asset Acquisition and Related Party Transaction     HTML     53K 
                (Details)                                                        
45: R30         Trade Receivables Allowances (Details)              HTML     23K 
46: R31         Inventories (Details)                               HTML     34K 
47: R32         Employee Share-Based Compensation (Details)         HTML     67K 
48: R33         Employee Share-Based Compensation (Details 1)       HTML     27K 
49: R34         Employee Share-Based Compensation (Details          HTML     34K 
                Narrative)                                                       
50: R35         Stock Issuance (Details Narrative)                  HTML     23K 
51: R36         Business Segments (Details)                         HTML     60K 
52: R37         Business Segments (Details 1)                       HTML     31K 
53: R38         Other Expense (Details Narrative)                   HTML     21K 
55: XML         IDEA XML File -- Filing Summary                      XML     88K 
54: EXCEL       IDEA Workbook of Financial Reports                  XLSX     45K 
10: EX-101.INS  XBRL Instance -- cdxc-20170701                       XML    771K 
12: EX-101.CAL  XBRL Calculations -- cdxc-20170701_cal               XML    114K 
13: EX-101.DEF  XBRL Definitions -- cdxc-20170701_def                XML    158K 
14: EX-101.LAB  XBRL Labels -- cdxc-20170701_lab                     XML    542K 
15: EX-101.PRE  XBRL Presentations -- cdxc-20170701_pre              XML    389K 
11: EX-101.SCH  XBRL Schema -- cdxc-20170701                         XSD     95K 
56: ZIP         XBRL Zipped Folder -- 0001654954-17-007224-xbrl      Zip     69K 


‘EX-10.7’   —   Fourth Business Financing Modification Agreement


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  SEC Connect  
 
Exhibit 10.7
 
FOURTH BUSINESS FINANCING MODIFICATION AGREEMENT
 
This Fourth Business Financing Modification Agreement (this “Agreement”) is entered into as of July 13, 2017, by and among CHROMADEX CORPORATION, a Delaware corporation, CHROMADEX, INC., a California corporation, CHROMADEX ANALYTICS, INC., a Nevada corporation and HEALTHSPAN RESEARCH LLC, a Delaware limited liability company (each, a “Borrower” and collectively, “Borrowers”), and WESTERN ALLIANCE BANK, an Arizona corporation (“Lender”).
 
1.             DESCRIPTION OF EXISTING INDEBTEDNESS: Among other indebtedness which may be owing by Borrowers to Lender, Borrowers are indebted to Lender pursuant to, among other documents, a Business Financing Agreement, dated November 4, 2016, by and among Borrowers and Lender, as may be amended from time to time, including, without limitation, by that certain First Business Financing Modification Agreement dated as of February 16, 2017, and that certain Second Business Financing Modification Agreement dated as of March 12, 2017 and that certain Third Business Financing Modification Agreement dated as of April 19, 2017 (the “Business Financing Agreement”). Capitalized terms used without definition herein shall have the meanings assigned to them in the Business Financing Agreement.
 
Hereinafter, all indebtedness owing by Borrowers to Lender under the Existing Documents (defined herein) shall be referred to as the “Obligations” and the Business Financing Agreement and any and all other Loan Documents executed by Borrowers in favor of Lender in connection therewith shall be referred to as the “Existing Documents.”
 
2.             DESCRIPTION OF CHANGE IN TERMS.
 
A.           Modifications to Business Financing Agreement and all Existing Documents:
 
(i) Section 4.13 of the Business Financing Agreement hereby is amended and restated in its entirety and replaced with the following:
 
4.13 Not make or contract to make, without Lender’s prior written consent, capital expenditures, including leasehold improvements, in any fiscal year in excess of $750,000 or incur liability for rentals of personal property (but excluding real property leases) in an amount which, together with capital expenditures, shall in any fiscal year exceed such sum.”
 
(ii) Section 12.1 of the Business Financing Agreement hereby is amended by amending and restating clause (c) of the definition of “Permitted Indebtedness” in its entirety to read as follows:
 
“(c) Purchase money indebtedness (including capital leases) incurred to acquire capital assets in ordinary course of business and not exceeding $750,000”
 
3.             CONSISTENT CHANGES. The Existing Documents are each hereby amended wherever necessary to reflect the changes described above.
 
4.             PAYMENT OF DOCUMENTATION FEE. Borrowers shall pay Lender all out-of-pocket expenses (including but not limited to reasonable legal fees and due diligence fees (if any)) incurred by Lender in connection with the execution of this Agreement.
 
5.             NO DEFENSES OF BORROWERS/GENERAL RELEASE. Each Borrower agrees that, as of this date, it has no defenses against the obligations to pay any amounts presently due under the Obligations. Each Borrower (each, a “Releasing Party”) acknowledges that Lender would not enter into this Agreement without Releasing Party’s assurance that it has no claims against Lender or any of Lender’s officers, directors, employees or agents. Except for the obligations arising hereafter under this Agreement, each Releasing Party releases Lender, and each of Lender’s and entity’s officers, directors and employees from any known or unknown claims that Releasing Party now has against Lender of any nature, including any claims that Releasing Party, its successors, counsel, and advisors may in the future discover they would have now had if they had known facts not now known to them, whether founded in contract, in tort or pursuant to any other theory of liability, including but not limited to any claims arising out of or related to the Agreement or the transactions contemplated thereby. Releasing Party waives the provisions of California Civil Code section 1542, which states:
 
 
-1-
 
 
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER, MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.
 
The provisions, waivers and releases set forth in this section are binding upon each Releasing Party and its shareholders, agents, employees, assigns and successors in interest. The provisions, waivers and releases of this section shall inure to the benefit of Lender and its agents, employees, officers, directors, assigns and successors in interest. The provisions of this section shall survive payment in full of the Obligations, full performance of all the terms of this Agreement and the Business Financing Agreement, and/or Lender’s actions to exercise any remedy available under the Business Financing Agreement or otherwise.
 
6.             CONTINUING VALIDITY. Borrowers understand and agree that in modifying the existing Business Financing Agreement, Lender is relying upon Borrowers’ representations, warranties, and agreements, as set forth in the Existing Documents. Except as expressly modified pursuant to this Agreement, the terms of the Existing Documents remain unchanged and in full force and effect. Lender’s agreement to modifications to the existing Business Financing Agreement pursuant to this Agreement in no way shall obligate Lender to make any future modifications to the Business Financing Agreement. Nothing in this Agreement shall constitute a satisfaction of the Obligations. It is the intention of Lender and Borrowers to retain as liable parties all makers and endorsers of Existing Documents, unless the party is expressly released by Lender in writing. No maker, endorser, or guarantor will be released by virtue of this Agreement except in accordance with the terms of this Agreement. The terms of this paragraph apply not only to this Agreement, but also to any subsequent Business Financing modification agreements.
 
7.             REFERENCE PROVISION.
 
A.           In the event the Jury Trial waiver is not enforceable, the parties elect to proceed under this Judicial Reference Provision.
 
B.           With the exception of the items specified in Section 8(c) below, any controversy, dispute or claim (each, a “Claim”) between the parties arising out of or relating to this Agreement or any other document, instrument or agreement between the undersigned parties (collectively in this Section, the “Loan Documents”), will be resolved by a reference proceeding in California in accordance with the provisions of Sections 638 et seq. of the California Code of Civil Procedure (“CCP”), or their successor sections, which shall constitute the exclusive remedy for the resolution of any Claim, including whether the Claim is subject to the reference proceeding. Except as otherwise provided in the Loan Documents, venue for the reference proceeding will be in the state or federal court in the county or district where the real property involved in the action, if any, is located or in the state or federal court in the county or district where venue is otherwise appropriate under applicable law (the “Court”).
 
C.           The matters that shall not be subject to a reference are the following: (i) nonjudicial foreclosure of any security interests in real or personal property, (ii) exercise of self-help remedies (including, without limitation, set-off), (iii) appointment of a receiver and (iv) temporary, provisional or ancillary remedies (including, without limitation, writs of attachment, writs of possession, temporary restraining orders or preliminary injunctions). This reference provision does not limit the right of any party to exercise or oppose any of the rights and remedies described in clauses (i) and (ii) or to seek or oppose from a court of competent jurisdiction any of the items described in clauses (iii) and (iv). The exercise of, or opposition to, any of those items does not waive the right of any party to a reference pursuant to this reference provision as provided herein.
 
D.           The referee shall be a retired judge or justice selected by mutual written agreement of the parties. If the parties do not agree within ten (10) days of a written request to do so by any party, then, upon request of any party, the referee shall be selected by the Presiding Judge of the Court (or his or her representative). A request for appointment of a referee may be heard on an ex parte or expedited basis, and the parties agree that irreparable harm would result if ex parte relief is not granted. Pursuant to CCP Sec. 170.6, each party shall have one peremptory challenge to the referee selected by the Presiding Judge of the Court (or his or her representative).
 
 
-2-
 
 
E.           The parties agree that time is of the essence in conducting the reference proceedings. Accordingly, the referee shall be requested, subject to change in the time periods specified herein for good cause shown, to (i) set the matter for a status and trial-setting conference within fifteen (15) days after the date of selection of the referee, (ii) if practicable, try all issues of law or fact within one hundred twenty (120) days after the date of the conference and (iii) report a statement of decision within twenty (20) days after the matter has been submitted for decision.
 
F.           The referee will have power to expand or limit the amount and duration of discovery. The referee may set or extend discovery deadlines or cutoffs for good cause, including a party’s failure to provide requested discovery for any reason whatsoever. Unless otherwise ordered based upon good cause shown, no party shall be entitled to “priority” in conducting discovery, depositions may be taken by either party upon seven (7) days written notice, and all other discovery shall be responded to within fifteen (15) days after service. All disputes relating to discovery which cannot be resolved by the parties shall be submitted to the referee whose decision shall be final and binding.
 
G.           Except as expressly set forth herein, the referee shall determine the manner in which the reference proceeding is conducted including the time and place of hearings, the order of presentation of evidence, and all other questions that arise with respect to the course of the reference proceeding. All proceedings and hearings conducted before the referee, except for trial, shall be conducted without a court reporter, except that when any party so requests, a court reporter will be used at any hearing conducted before the referee, and the referee will be provided a courtesy copy of the transcript. The party making such a request shall have the obligation to arrange for and pay the court reporter. Subject to the referee’s power to award costs to the prevailing party, the parties will equally share the cost of the referee and the court reporter at trial.
 
H.           The referee shall be required to determine all issues in accordance with existing case law and the statutory laws of the State of California. The rules of evidence applicable to proceedings at law in the State of California will be applicable to the reference proceeding. The referee shall be empowered to enter equitable as well as legal relief, enter equitable orders that will be binding on the parties and rule on any motion which would be authorized in a court proceeding, including without limitation motions for summary judgment or summary adjudication. The referee shall issue a decision at the close of the reference proceeding which disposes of all claims of the parties that are the subject of the reference. Pursuant to CCP Sec. 644, such decision shall be entered by the Court as a judgment or an order in the same manner as if the action had been tried by the Court and any such decision will be final, binding and conclusive. The parties reserve the right to appeal from the final judgment or order or from any appealable decision or order entered by the referee. The parties reserve the right to findings of fact, conclusions of laws, a written statement of decision, and the right to move for a new trial or a different judgment, which new trial, if granted, is also to be a reference proceeding under this provision.
 
I.           If the enabling legislation which provides for appointment of a referee is repealed (and no successor statute is enacted), any dispute between the parties that would otherwise be determined by reference procedure will be resolved and determined by arbitration. The arbitration will be conducted by a retired judge or justice, in accordance with the California Arbitration Act Sec.1280 through Sec.1294.2 of the CCP as amended from time to time. The limitations with respect to discovery set forth above shall apply to any such arbitration proceeding.
 
J.           THE PARTIES RECOGNIZE AND AGREE THAT ALL CONTROVERSIES, DISPUTES AND CLAIMS RESOLVED UNDER THIS REFERENCE PROVISION WILL BE DECIDED BY A REFEREE AND NOT BY A JURY. AFTER CONSULTING (OR HAVING HAD THE OPPORTUNITY TO CONSULT) WITH COUNSEL OF ITS, HIS OR HER OWN CHOICE, EACH PARTY KNOWINGLY AND VOLUNTARILY, AND FOR THE MUTUAL BENEFIT OF ALL PARTIES, AGREES THAT THIS REFERENCE PROVISION WILL APPLY TO ANY CONTROVERSY, DISPUTE OR CLAIM BETWEEN OR AMONG THEM ARISING OUT OF OR IN ANY WAY RELATED TO, THIS AGREEMENT OR THE OTHER LOAN DOCUMENTS.
 
8.             CONDITIONS. The effectiveness of this Agreement is conditioned upon Lender’s receipt of the following, in form and substance satisfactory to Lender:
 
(a)           this Agreement, duly executed by Borrowers;
 
 
-3-
 
 
(b)           payment of all reasonable expenses incurred by Lender in connection with the execution hereof, which may be debited from any of Borrowers' accounts; and
 
(c)           such other documents, and completion of such other matters, as Lender may reasonably deem necessary or appropriate.
 
9.             NOTICE OF FINAL AGREEMENT. BY SIGNING THIS DOCUMENT EACH PARTY REPRESENTS AND AGREES THAT: (A) THIS WRITTEN AGREEMENT REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES, (B) THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES, AND (C) THIS WRITTEN AGREEMENT MAY NOT BE CONTRADICTED BY EVIDENCE OF ANY PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR UNDERSTANDINGS OF THE PARTIES.
 
10.             COUNTERSIGNATURE. This Agreement shall become effective only when executed by Lender and Borrowers.
 
 
 
[Balance of Page Intentionally Left Blank]
 
 

 
-4-
 
 
IN WITNESS WHEREOF, Borrowers and Lender have executed this Agreement on the date and year above written.
 
 
BORROWERS:
 
 
 
 
 
 
CHROMADEX CORPORATION,
a Delaware corporation
 
 
 
 
 
 
 
 
By: /s/ Thomas C. Varvaro
 
 
Name: Thomas C. Varvaro
 
 
Title: CFO
 
 
 
 
 
 
CHROMADEX, INC.,
a California corporation
 
 
 
 
 
 
 
 
By: /s/ Thomas C. Varvaro
 
 
Name: Thomas C. Varvaro
 
 
Title: CFO
 
 
 
 
CHROMADEX ANALYTICS, INC.,
a Nevada corporation
 
 
 
 
 
 
 
 
By: /s/ Thomas C. Varvaro
 
 
Name: Thomas C. Varvaro
 
 
Title: CFO
 
 
 
 
 
 
 
 
HEALTHSPAN RESEARCH LLC,
a Delaware limited liability company
 
 
 
 
 
 
 
 
By: /s/ Thomas C. Varvaro
 
 
Name: Thomas C. Varvaro
 
 
Title: CFO
 
 
 
 
 
 
[Signature Page to Fourth Business Financing Modification Agreement]
 
[Signatures continued on the next page]
 
 
 
-5-
 
 
IN WITNESS WHEREOF, Borrowers and Lender have executed this Agreement on the date and year above written.
 
LENDER:
 
 
WESTERN ALLIANCE BANK,
an Arizona corporation
 
 
By: /s/ Grant Simon
Name: Grant Simon
Title: AVP
 
 
 
[Signature Page to Fourth Business Financing Modification Agreement]
 
 
-6-

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/10/178-K,  DEF 14A
7/13/17
For Period end:7/1/17
4/19/178-K
3/12/174
2/16/17
11/4/168-K
 List all Filings 
Top
Filing Submission 0001654954-17-007224   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 11:42:30.1am ET